896
Views
23
CrossRef citations to date
0
Altmetric
Articles

Role of community pharmacists in medication management during COVID-19 lockdown

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon

References

  • Sharma A, Tiwari S, Deb MK, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054.
  • Elflein J. Coronavirus (COVID-19) disease pandemic-statistics & facts. New York, USA: Statista. 2020. [accessed 6 Dec 2020]. Available from: https://www.statista.com/topics/5994/the-coronavirus-disease-covid-19-outbreak/
  • Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29.
  • Al-Tammemi AB. The battle against COVID-19 in Jordan: an early overview of the Jordanian experience. Front Public Health. 2020;8:188.
  • Worldometer. 2020. [accessed 29 Nov 2020]  Available from: https://www.worldometers.info/world-population/jordan-population/.
  • World Bank Open Data. 2019. [accessed 29 Nov 2020]. Available from: https://data.worldbank.org/country/jordan?display=grap.
  • The International Trade Administration-US Department of Commerce. 2016.[cited 29 Nov 2020]. Available from: https://www.trade.gov/export-solutions.
  • Medical Toursim Index. 2020. [accessed 29 Nov 2020]. Available from: https://www.medicaltourism.com/mti/home.
  • Rashad AS, Sharaf MF. Catastrophic economic consequences of healthcare payments: effects on poverty estimates in Egypt, Jordan, and Palestine. Economies. 2015;3(4):216–234.
  • High Health Council and the World Health Organization. The national strategy for health sector in Jordan 2015–2019. USAID/Jordan Monitoring and Evaluation Support Program (MESP). Amman, Jordan; 2019.
  • Kretchy IA, Asiedu-Danso M, Kretchy J-P. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from LMICs. Res Social Adm Pharm. 2020;17(1):2023–2026.
  • DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.
  • Management of visitors to healthcare facilities in the context of COVID-19: non-US healthcare settings: centers for disease control and prevention; 2020. [updated 15 Sep 2020; accessed 6 Dec 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/hcf-visitors.html.
  • Hindi AMK, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: a systematic review. Health Expect. 2018;21(2):409–428.
  • Sousa Pinto G, Bader L, Billberg K, et al. Beating non-communicable diseases in primary health care: the contribution of pharmacists and guidance from FIP to support WHO goals. Res Soc Admin Pharm. 2020;16(7):974–977.
  • Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Admin Pharm. 2020. DOI:10.1016/j.sapharm.2020.04.017
  • Hamed SH. Community pharmacy practice during COVID-19 pandemic: a perspective from the Middle East. J Qual Health Care. 2020;3(3):109–114.
  • Abdel Jalil M, Alsous MM, Abu Hammour K, et al. Role of pharmacists in COVID-19 disease: a Jordanian perspective. Disaster medicine and public health preparedness. Cambridge University Press: Cambridge, United Kingdom. 2020. p. 1–7. doi:10.1017/dmp.2020.186
  • Pannucci CJ, Wilkins EG. Identifying and avoiding bias in research. Plast Reconstr Surg. 2010;126(2):619–625.
  • Azlan AA, Hamzah MR, Sern TJ, et al. Public knowledge, attitudes and practices towards COVID-19: a cross-sectional study in Malaysia. PloS One. 2020;15(5):e0233668.
  • Inc R. Sample size calculator [Accessed 5 Jan 2020]. Available from: http://www.raosoft.com/samplesize.html.
  • van Griethuijsen RALF, van Eijck MW, Haste H, et al. Global patterns in students’ views of science and interest in science. Res Sci Educ. 2015;45(4):581–603.
  • Ababsa M. The socio-economic composition of the population. Beirut, Lebanon: Presses de l’Ifpo; 2013.
  • Khader Y, Batieha A, Jaddou H, et al. Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:3210617.
  • Alghadir A, Alghwiri AA, Awad H, et al. Ten-year diabetes risk forecast in the capital of Jordan: Arab diabetes risk assessment questionnaire perspective-a strobe-complaint article. Medicine (Baltimore). 2016;95(12):e3181.
  • Saydah SH, Imperatore G, Beckles GL. Socioeconomic status and mortality: contribution of health care access and psychological distress among U.S. adults with diagnosed diabetes. Diabetes Care. 2013;36(1):49–55.
  • Lee H, Park JH, Floyd JS, et al. Combined effect of income and medication adherence on mortality in newly treated hypertension: nationwide study of 16 million person-years. J Am Heart Assoc. 2019;8(16):e013148.
  • Booth GL, Bishara P, Lipscombe LL, et al. Universal drug coverage and socioeconomic disparities in major diabetes outcomes. Diabetes Care. 2012;35(11):2257–2264.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.